2,4-diaminopyridine has been researched along with Local Neoplasm Recurrence in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, A; Chaturvedi, P; Dubrovskiy, A; Etter, J; Harding, TC; Haringsma, H; Karp, R; Labenski, MT; Lee, K; Martin, TS; Medikonda, A; Nacht, M; Niu, D; Petter, RC; Raponi, M; Ren, Y; Sheets, M; Simmons, AD; Singh, J; Tester, R; Tjin Tham Sjin, R; Walter, AO; Westlin, WF; Zhu, Z | 1 |
1 other study(ies) available for 2,4-diaminopyridine and Local Neoplasm Recurrence
Article | Year |
---|---|
In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing.
Topics: 4-Aminopyridine; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Clinical Trials as Topic; Drug Resistance, Neoplasm; ErbB Receptors; Humans; In Vitro Techniques; Mice; Mutation; Neoplasm Recurrence, Local; Xenograft Model Antitumor Assays | 2014 |